Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPTAIN: Cilostazol for Preventing Delayed Cerebral Ischemia in aSAH
NCT07249853Phase 3Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Dec 2025
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cilostazol in aneurysmal subarachnoid hemorrhage (SAH), sponsored by Beijing Tiantan Hospital. Started Dec 2025; status: recruiting.
02
Drugs
cilostazol
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT07249853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07249853.